Envestnet Portfolio Solutions Inc. Purchases 10,315 Shares of CME Group Inc. $CME

Key Points

• Envestnet Portfolio Solutions Inc. increased its holdings in CME Group Inc. by 22.0%, acquiring an additional 10,315 shares, bringing its total to 57,124 shares valued at approximately $15.74 million.
• Several institutional investors, including Wealth Enhancement Advisory Services LLC, significantly increased their stakes in CME Group during the first quarter, with Wealth Enhancement acquiring 40,592 more shares for a total of 105,044 shares.
• The quarterly earnings report showed CME Group's EPS at $2.96, exceeding analyst expectations, with a revenue increase of 10.4% year-over-year, totaling $1.69 billion.

Envestnet Portfolio Solutions Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 22.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 57,124 shares of the financial services provider's stock after acquiring an additional 10,315 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in CME Group were worth $15,744,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. GAMMA Investing LLC lifted its holdings in shares of CME Group by 24.5% during the 1st quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider's stock worth $1,859,000 after acquiring an additional 1,381 shares during the period. Stock Yards Bank & Trust Co. bought a new stake in shares of CME Group during the 1st quarter worth approximately $210,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of CME Group by 63.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider's stock worth $27,867,000 after acquiring an additional 40,592 shares during the period. Dynamic Advisor Solutions LLC lifted its holdings in shares of CME Group by 3.1% during the 1st quarter. Dynamic Advisor Solutions LLC now owns 2,533 shares of the financial services provider's stock worth $672,000 after acquiring an additional 76 shares during the period. Finally, Ritholtz Wealth Management lifted its holdings in shares of CME Group by 10.3% during the 1st quarter. Ritholtz Wealth Management now owns 4,451 shares of the financial services provider's stock worth $1,181,000 after acquiring an additional 416 shares during the period. Institutional investors own 87.75% of the company's stock.

Insider Activity

In other news, Director William R. Shepard acquired 262 shares of the firm's stock in a transaction dated Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the transaction, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company's stock, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Down 0.1%

Shares of NASDAQ CME opened at $271.28 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79. The firm has a 50 day moving average price of $268.57 and a two-hundred day moving average price of $271.35. The stock has a market cap of $97.76 billion, a P/E ratio of 26.26, a price-to-earnings-growth ratio of 5.72 and a beta of 0.41.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period in the prior year, the company posted $2.56 EPS. The company's revenue was up 10.4% on a year-over-year basis. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group's dividend payout ratio is 48.40%.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of CME Group from $276.00 to $266.00 and set a "hold" rating for the company in a research note on Thursday, October 9th. Citigroup raised shares of CME Group from a "neutral" rating to a "buy" rating and increased their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Jefferies Financial Group dropped their price objective on shares of CME Group from $313.00 to $304.00 and set a "buy" rating for the company in a research note on Friday. Finally, Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, CME Group currently has a consensus rating of "Hold" and a consensus target price of $283.43.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.